A. Bouchla

发表

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma

M. Dimopoulos, A. Kotanidou, S. Papageorgiou, 2021, Viruses.

Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine.

S. Papageorgiou, V. Pappa, T. Thomopoulos, 2021, Epigenomics.

Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes

S. Papageorgiou, G. Pavlidis, V. Pappa, 2021, Therapeutic advances in hematology.

Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the ‘real life’ setting: A single center observational study

S. Papageorgiou, G. Dimitriadis, C. Kontos, 2016, Hematology.

Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes

S. Papageorgiou, V. Pappa, E. Hatzimichael, 2020, Hematological oncology.

Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group

S. Papageorgiou, A. Spathis, A. Symeonidis, 2020, Hematological oncology.

Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study

Aikaterini N Panagiotou, S. Papageorgiou, A. Pouliakis, 2022, Frontiers in Physiology.

Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De‐Novo, Particularly Low‐Grade Myelodysplastic Syndromes

S. Papageorgiou, A. Spathis, G. Dimitriadis, 2018, Cytometry. Part B, Clinical cytometry.

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

S. Papageorgiou, E. Hatzimichael, P. Repousis, 2019, Journal of geriatric oncology.

The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group

S. Papageorgiou, E. Hatzimichael, P. Repousis, 2018, Hematological oncology.

Prognostic significance of monoclonal gammopathy in diffuse large B‐cell lymphoma

S. Papageorgiou, A. Spathis, P. Foukas, 2019, Hematological oncology.

A Prospective Phase II Study on The Use Of Convalescent Plasma Monotherapy For The Treatment of Severe Covid-19 Disease: A Preliminary Report.

M. Dimopoulos, A. Kotanidou, S. Papageorgiou, 2020 .

The Addition of Strength Training to Aerobic Interval Training: Effects on Muscle Strength and Body Composition in CHF Patients

J. Terrovitis, E. Tseliou, N. Diakos, 2011, Journal of cardiopulmonary rehabilitation and prevention.

Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications

S. Papageorgiou, V. Pappa, T. Thomopoulos, 2021, Therapeutic advances in hematology.

Human Herpesvirus-7 Encephalitis Following Treatment with Obinutuzumab-CHOP in a Patient with Non-Hodgkin Follicular Lymphoma: A Case Report

G. Velonakis, G. Sotirios, M. Papathanasiou, 2022, Annals of Case Reports.

MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia

A. Scorilas, S. Papageorgiou, C. Kontos, 2018, Leukemia & lymphoma.

Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

A. Scorilas, S. Papageorgiou, C. Kontos, 2018, Leukemia research.

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis

A. Scorilas, S. Papageorgiou, C. Kontos, 2017, Disease markers.

Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report

S. Papageorgiou, P. Foukas, G. Pavlidis, 2018, Case reports in hematology.

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis

M. Dimopoulos, A. Kotanidou, S. Papageorgiou, 2021, Microorganisms.

Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience

S. Papageorgiou, G. Dimitriadis, P. Tsirigotis, 2019, Advances in hematology.

Clinical Study Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience

S. Papageorgiou, G. Dimitriadis, P. Tsirigotis, 2019 .

Solitary extramedullary plasmacytoma of the nasopharynx: The role of flow cytometry.

S. Papageorgiou, A. Spathis, P. Foukas, 2021, Oral oncology.

Systemic Mastocytosis in a Patient with BCR-ABL1-Positive Chronic Myeloid Leukemia in the Remission Phase

S. Papageorgiou, A. Katoulis, P. Foukas, 2022, Case reports in hematology.

Erdheim–Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report

S. Papageorgiou, A. Mavrogenis, M. Roumelioti, 2020, OncoTargets and therapy.

Primary Adrenal Lymphomas with Cushing’s Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells

N. Thomaidis, M. Peppa, S. Papageorgiou, 2023, Journal of clinical medicine.

S. Papageorgiou, A. Spathis, A. Symeonidis, 2021, Hematological Oncology.

Multiple osteolytic lesions due to Double-Expressor Primary non-Hodgkin Lymphoma of the Bone

S. Papageorgiou, A. Papanikolaou, V. Pappa, 2020, Autopsy & case reports.

Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

A. Scorilas, S. Papageorgiou, C. Kontos, 2018, Leukemia research.

Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece

S. Papageorgiou, A. Symeonidis, V. Pappa, 2024, Journal of clinical medicine.